Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001387131-13-002242)

Filing Details

Accession Number:: 0001387131-13-002242
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-06-17 18:58:47
Reporting Period:: 2013-06-14

Filing Date:: 2013-06-17
Accepted Time:: 2013-06-17 18:58:47
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
25743	Therapeuticsmd Inc.	TXMD	Pharmaceutical Preparations (2834)	870233535

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1485508	C. Cooper Collins	10003 Woodloch Forest #950 The Woodlands TX 77380		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-06-14	2,631,579	$1.75	0	No	4	S	Indirect	Permix Therapeutics Holdings, Inc.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Permix Therapeutics Holdings, Inc.

Footnotes

The sale of the 2,631,579 shares was made by Pernix Therapeutics Holdings, Inc. ("Pernix"). Mr. Collins is an officer, director and largest shareholder of Pernix and exercises voting control in part with the remaining directors of Pernix; however,he disclaims beneficial ownership of the shares.